TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK
TRIV
TRIV was delisted on the 3rd of February, 2016.
26 hedge funds and large institutions have $64.1M invested in TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK in 2015 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 12 closing their positions.
33% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 6
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
19% less capital invested
Capital invested by funds: $79.6M → $64.1M (-$15.5M)
28% less funds holding
Funds holding: 36 → 26 (-10)
83% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$387K |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
+$103K |
| 3 |
Bank of New York Mellon
New York
|
+$86.9K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$39.4K |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$26.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Stifel Financial
St. Louis,
Missouri
|
-$1.83M |
| 2 |
Northern Trust
Chicago,
Illinois
|
-$343K |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$209K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$122K |
| 5 |
Millennium Management
New York
|
-$89K |
TRIV Hedge Fund Activity: Q3 2015 in Review
26 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK (TRIV) for Q3 2015, worth a combined $64.1M — down 19% from $79.6M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of TRIV and 2 opened new positions — a net loss of 10 holders — while 6 trimmed existing stakes and 8 added.
The largest buyer was Goldman Sachs, adding an estimated $387K. The largest seller was Stifel Financial, cutting an estimated $1.83M.
- 26 institutional investors held TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK (TRIV) as of Q3 2015, down from 36 in Q2 2015.
- Funds reported $64.1M of TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK stock for Q3 2015, down 19% quarter-over-quarter.
- 2 funds opened new TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK positions in Q3 2015 and 12 closed out, a net change of -10 holders.
- The largest TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK buyer in Q3 2015 was Goldman Sachs, an estimated $387K added.
- The largest TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK seller in Q3 2015 was Stifel Financial, an estimated $1.83M sold.
Based on aggregated 13F filings for Q3 2015.